Evidence map›Paper›PMID 26113014›Full record

ReviewCurrent rheumatology reports2015

Implementation of Functional Genomics for Bench-to-Bedside Transition in Osteoarthritis.

Yolande F M Ramos, Ingrid Meulenbelt

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current rheumatology reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. The association ofTherapeutics and clinical risk management · 2017
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yolande F M RamosDepartment of Molecular Epidemiology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC, Leiden, The Netherlands, y.f.m.ramos@lumc.nl.
Ingrid Meulenbelt

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Collaborative work has led to the identification of robust osteoarthritis susceptibility genes. The translation of these gene deviations towards underlying biological mechanisms remains challenging yet necessary to allow the transition of these results in drug development and to applications in the clinic. Besides the availability of disease-relevant tissues which will contribute to a deeper insight into ongoing pathophysiological processes as result of the gene deviations, availability of respective cells will be key to establish in vitro models to further characterize genetic variants at a transcriptional and functional level. To allow exploration of effective use of drugs and biologicals such findings should eventually be further tested in in vivo models. In this review, we discuss possibilities for the implementation of an effective functional genomic pipeline for bench-to-bedside translation of identified susceptibility loci.

Indexed as

AnimalsArthritis, ExperimentalBiological Specimen BanksCells, CulturedGenetic Predisposition to DiseaseGenome-Wide Association StudyGenomicsHumansOsteoarthritisPolymorphism, Single NucleotideTranslational Research, Biomedical

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.